Loading…

A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: In vitro and in vivo study

Highlights ► KR-22332 is a novel otoprotective synthetic compound against cisplatin-induced ototoxicity. ► KR-22332 protected auditory cells from cisplatin by blocking the change of MMP and ROS. ► KR-22332 inhibited the activation of MAPKs and inflammatory cytokines by cisplatin. ► Transtympanic adm...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience 2013-03, Vol.232, p.1-12
Main Authors: Shin, Y.S, Song, S.J, Kang, S.U, Hwang, H.S, Choi, J.W, Lee, B.H, Jung, Y.-S, Kim, C.-H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► KR-22332 is a novel otoprotective synthetic compound against cisplatin-induced ototoxicity. ► KR-22332 protected auditory cells from cisplatin by blocking the change of MMP and ROS. ► KR-22332 inhibited the activation of MAPKs and inflammatory cytokines by cisplatin. ► Transtympanic administration of KR-22332 in a rat model was protective against cisplatin-induced hearing loss. ► KR-22332 can be delivered topically through the middle ear, minimizing systemic effects.
ISSN:0306-4522
1873-7544
DOI:10.1016/j.neuroscience.2012.12.008